Literature DB >> 26479499

Perinatal outcomes of fetal pleural effusion following thoracoamniotic shunting.

Ba-Da Jeong1, Hye-Sung Won1, Mi-Young Lee1, Jae-Yoon Shim1, Pil-Ryang Lee1, Ahm Kim1.   

Abstract

OBJECTIVE: The aim is to evaluate perinatal outcomes of fetal pleural effusion after thoracoamniotic shunting.
METHODS: This was a retrospective study of 68 singleton pregnancies with massive fetal pleural effusion that underwent thoracoamniotic shunting between 1999 and 2012 at Asan Medical Center, Seoul, Korea. Through a review of medical records, we investigated perinatal outcomes according to the presence of fetal hydrops and identified prognostic factors by stepwise multivariate logistic regression analysis.
RESULTS: Of the 68 pregnancies, three were lost to follow-up and two fetuses died in utero. The median gestational age at shunting was 28.3 weeks (range, 18.5-34.1 weeks). Of the 65 fetuses, 50 (76.9%) were hydropic, of which hydrops resolved following shunting in 29 fetuses (58.0%). Among the 63 live births, the median gestational age at delivery was 33.6 weeks (range, 26.2-40.0 weeks), with 36 fetuses (57.1%) delivered preterm. The overall survival rate was 75.4% (49/65), and in a subgroup analysis, the survival rate was highest for non-hydropic fetuses (14/15, 93.3%), followed by fetuses whose hydrops resolved (25/29, 86.2%) and remained after shunting (10/21, 47.6%).
CONCLUSION: Thoracoamniotic shunting can be helpful for fetuses with massive pleural effusion. While fetal hydrops can occur in such cases, perinatal outcomes can be improved by successful shunting.
© 2015 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26479499     DOI: 10.1002/pd.4709

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  4 in total

1.  Systematic review of pleural-amniotic shunt insertion vs. conservative management in isolated bilateral fetal hydrothorax without hydrops.

Authors:  Elaine Carson; Priscilla Devaseelan; Stephen Ong
Journal:  Ir J Med Sci       Date:  2019-11-19       Impact factor: 1.568

2.  Care Levels for Fetal Therapy Centers.

Authors:  Ahmet A Baschat; Sean B Blackwell; Debnath Chatterjee; James J Cummings; Stephen P Emery; Shinjiro Hirose; Lisa M Hollier; Anthony Johnson; Sarah J Kilpatrick; Francois I Luks; M Kathryn Menard; Lawrence B McCullough; Julie S Moldenhauer; Anita J Moon-Grady; George B Mychaliska; Michael Narvey; Mary E Norton; Mark D Rollins; Eric D Skarsgard; KuoJen Tsao; Barbara B Warner; Abigail Wilpers; Greg Ryan
Journal:  Obstet Gynecol       Date:  2022-05-02       Impact factor: 7.623

3.  Intrauterine Thoracoamniotic Shunting of Fetal Hydrothorax with the Somatex Intrauterine Shunt: Intrauterine Course and Postnatal Outcome.

Authors:  Joleen Grandt; Ingo Gottschalk; Annegret Geipel; Ulrich Gembruch; Corinna Simonini; Eva Weber; Christoph Berg; Andreas Müller; Brigitte Strizek
Journal:  J Clin Med       Date:  2022-04-21       Impact factor: 4.241

Review 4.  Fetal therapies as standard prenatal care in Japan.

Authors:  Haruhiko Sago; Seiji Wada
Journal:  Obstet Gynecol Sci       Date:  2020-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.